You have 9 free searches left this month | for more free features.

Programmed Cell Death-1 (PD1, PD-1)

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease Trial in New York (OBP-301,

Terminated
  • Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
  • New York, New York
    Weill Cornell Medicine
Jul 6, 2022

Renal Transplant Rejection, Renal Transplant Infection Trial (Tacrolimus)

Not yet recruiting
  • Renal Transplant Rejection
  • Renal Transplant Infection
  • (no location specified)
Nov 1, 2022

Bulbar Function, Speech And Communication Development in SMA

Not yet recruiting
  • SMA1
    • (no location specified)
    Jul 12, 2023

    Advanced Malignant Solid Tumors, TGCT Trial in China (HMPL-653)

    Recruiting
    • Advanced Malignant Solid Tumors
    • TGCT
    • Chang chun, China
    • +4 more
    Mar 11, 2022

    Selecting the SSV-1 as LIV in Scheuermann's Kyphosis

    Completed
    • Scheuermann's Kyphosis
    • Select the vertebra above sagittal stable vertebra as the distal fusion level
    • Nanjing, Jiang Su, China
      Drum Tower Hospital of Nanjing University Medical School
    Jul 18, 2023

    Small Cell Ovarian Carcinoma Trial in France (Pembrolizumab 25 MG/ML [Keytruda])

    Recruiting
    • Small Cell Ovarian Carcinoma
    • Pembrolizumab 25 MG/ML [Keytruda]
    • Angers, France
    • +10 more
    Jul 13, 2022

    Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)

    Completed
    • Advanced Parkinson's Disease
    • Little Rock, Arkansas
    • +10 more
    May 11, 2022

    Non-Alcoholic Fatty Liver Disease Trial in Porto (BAR502, Placebo)

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • Porto, Portugal
      BlueClinical Phase I
    Jan 5, 2022

    Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine, Placebo)

    Completed
    • Symptomatic Neurogenic Orthostatic Hypotension
    • Sun City, Arizona
    • +124 more
    Sep 15, 2021

    Trauma Follow-Up Prediction (Project 2: Aim 1)

    Not yet recruiting
    • Trauma
    • +2 more
    • Standard mHealth screening (triage) tool
    • (no location specified)
    Jun 17, 2022

    Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • Neuroendocrine Neoplasms
    • (no location specified)
    May 25, 2023

    KRAS p, G12c Mutated /Advanced Metastatic NSCLC Trial in Worldwide (AMG 510, Docetaxel)

    Active, not recruiting
    • KRAS p, G12c Mutated /Advanced Metastatic NSCLC
    • Anaheim, California
    • +273 more
    Nov 10, 2022

    Phantom Limb Pain, Pain, Chronic Trial in Medellin (Epidural catheter, Continuous sciatic nerve block)

    Not yet recruiting
    • Phantom Limb Pain
    • Pain, Chronic
    • Epidural catheter
    • Continuous sciatic nerve block
    • Medellin, Colombia
      Antioquia´s University
    Nov 2, 2022

    Type 2 Diabetes, Chronic Kidney Diseases Trial (Renal Autologous Cell Therapy (REACT®))

    Not yet recruiting
    • Type 2 Diabetes Mellitus
    • Chronic Kidney Diseases
    • Renal Autologous Cell Therapy (REACT)
    • (no location specified)
    Jan 6, 2023

    Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative Trial in Canada (Lidocaine 20mg/ml, Placebo)

    Recruiting
    • Post-mastectomy Pain Syndrome
    • +3 more
    • Lidocaine 20mg/ml
    • Placebo
    • Calgary, Alberta, Canada
    • +11 more
    Nov 24, 2022

    Gastric Cancer Trial in Beijing (Intraperitoneal chemo, Adjuvant systemic chemo)

    Recruiting
    • Gastric Cancer
    • Intraperitoneal chemotherapy
    • Adjuvant systemic chemotherapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Aug 10, 2022

    T-cell Repertoire in Acute Myeloid Leukemia Undergoing Donor

    Recruiting
    • Acute Myeloid Leukemia
    • Biospecimen Collection
    • Laboratory Biomarker Analysis
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Nov 16, 2021

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

    Not yet recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
    • SC-CAR4BRAIN
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 3, 2023

    Lung Diseases Trial in João Pessoa (Active non-invasive stimulation and inspiratory muscle training, Sham compatorator and

    Recruiting
    • Lung Diseases
    • Active non-invasive stimulation and inspiratory muscle training
    • Sham compatorator and inspiratory muscle training
    • João Pessoa, Paraiba, Brazil
      Federal University of Paraiba
    May 23, 2023

    Intravascular Imaging and Microvascular Obstruction Trial (OCT-guided PCI, 60 MHz HD-IVUS-guided PCI, Angiography-guided PCI)

    Not yet recruiting
    • Intravascular Imaging and Microvascular Obstruction
    • OCT-guided PCI
    • +2 more
    • (no location specified)
    Nov 23, 2023

    Post-COVID19 Condition Trial in Badalona (Plasma Exchange Procedure, Sham Plasma Exchange Procedure)

    Recruiting
    • Post-COVID19 Condition
    • Plasma Exchange Procedure
    • Sham Plasma Exchange Procedure
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol Hospital
    Oct 3, 2022

    Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)

    Not yet recruiting
    • Bacterial Infections
    • (no location specified)
    Nov 27, 2023

    Sickle Cell Disease Trial in Los Angeles (ßAS3-FB vector transduced peripheral blood CD34+ cells)

    Recruiting
    • Sickle Cell Disease
    • βAS3-FB vector transduced peripheral blood CD34+ cells
    • Los Angeles, California
      University of California, Los Angeles (UCLA)
    Apr 9, 2022

    Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)

    Recruiting
    • Healthy
    • Enteric Hyperoxaluria
    • FB-001
    • Placebo
    • Cincinnati, Ohio
      Medpace Clinical Pharmacology Unit
    Jan 23, 2023

    Type 1 Diabetes Trial (Gluten Free Diet, Placebo)

    Terminated
    • Type 1 Diabetes Mellitus
    • Gluten Free Diet
    • Placebo
    • (no location specified)
    Oct 31, 2022